These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 28093977)

  • 1. The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind.
    Ricciarelli R; Fedele E
    Curr Neuropharmacol; 2017; 15(6):926-935. PubMed ID: 28093977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis.
    Fedele E
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and the amyloid cascade hypothesis: ten years on.
    Sommer B
    Curr Opin Pharmacol; 2002 Feb; 2(1):87-92. PubMed ID: 11786314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Karran E; Mercken M; De Strooper B
    Nat Rev Drug Discov; 2011 Aug; 10(9):698-712. PubMed ID: 21852788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?
    Saxena U
    Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.
    Hardy J
    J Neurochem; 2009 Aug; 110(4):1129-34. PubMed ID: 19457065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amyloid cascade hypothesis: are we poised for success or failure?
    Karran E; De Strooper B
    J Neurochem; 2016 Oct; 139 Suppl 2():237-252. PubMed ID: 27255958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
    Gulisano W; Maugeri D; Baltrons MA; Fà M; Amato A; Palmeri A; D'Adamio L; Grassi C; Devanand DP; Honig LS; Puzzo D; Arancio O
    J Alzheimers Dis; 2018; 64(s1):S611-S631. PubMed ID: 29865055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
    Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
    ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.
    Creed MC; Milgram NW
    Age (Dordr); 2010 Sep; 32(3):365-84. PubMed ID: 20640545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal.
    Hardy J
    J Alzheimers Dis; 2006; 9(3 Suppl):151-3. PubMed ID: 16914853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
    Cho JE; Kim JR
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
    Klein WL
    J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The underexplored question of β-amyloid monomers.
    Copani A
    Eur J Pharmacol; 2017 Dec; 817():71-75. PubMed ID: 28577967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amyloid cascade hypothesis has misled the pharmaceutical industry.
    Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.